Resistant Hypertension: Opportunity Assessment and Forecast

This report covers the 7MM (US, 5EU, Japan) and provides an Excel-based forecast model for the RH market through 2034.

• There will be an overall increase in the diagnosed prevalent cases of RH in the 7MM across the forecast period.
• There are many treatment options available, particularly in the ACE inhibitor and ARB classes, where genericized therapies are favoured due to their low cost and wider availability.
• Significant clinical and environmental unmet needs remain in the RH market.
• The RH market across the 7MM was valued at $2.6 billion in 2024 and is expected to grow to $13.5 billion by 2034 at a compound annual growth rate (CAGR) of 17.3%.

Scope

• Overview of RH, including epidemiology, symptoms, diagnosis, and disease management.
• Annualized RH therapeutics market revenue in 7MM (US, 5EU, and Japan), annual cost of therapy and treatment usage pattern in 2024 and forecast for 10 years to 2034.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the RH therapeutics market.
• Pipeline analysis, comprehensive data assessing emerging trends and mechanisms of action under development for RH treatment. The most promising candidates in late-stage development are profiled.
• Analysis of the current and future market competition in the 7MM RH therapeutics market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the RH therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the RH therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.